What is he best known for?
The fields of study he is best known for:
- Antibiotics
- Bacteria
- Internal medicine
His primary areas of study are Microbiology, Drug resistance, Antibiotic resistance, Antimicrobial susceptibility and Biotechnology.
Microbiology is closely attributed to Bacteria in his research.
The Drug resistance study combines topics in areas such as Antibiotics, Fosfomycin, Ceftolozane, Plazomicin and Escherichia coli.
His work focuses on many connections between Antibiotic resistance and other disciplines, such as Public health, that overlap with his field of interest in Absolute number and Disease.
Gunnar Kahlmeter has researched Antimicrobial susceptibility in several fields, including Clinical microbiology, Horse blood and Mueller-Hinton agar.
Gunnar Kahlmeter interconnects Pseudomonas aeruginosa, Multiple drug resistance, Enterococcus and Acinetobacter in the investigation of issues within Antimicrobial.
His most cited work include:
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance (4863 citations)
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis (1203 citations)
- The global threat of antimicrobial resistance: science for intervention (486 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Microbiology, Antimicrobial susceptibility, Antibiotic resistance, Antibiotics and Antimicrobial.
His Microbiology research incorporates elements of Staphylococcus aureus, Agar and Escherichia coli.
His Antimicrobial susceptibility study incorporates themes from Clostridium difficile, Broth microdilution, Biotechnology and Computational biology.
His Antibiotic resistance research incorporates elements of Infection control, Virology, Environmental health, Public health and Drug resistance.
His Antimicrobial research is multidisciplinary, incorporating perspectives in Inhibition zone and Intensive care medicine.
His Klebsiella pneumoniae research includes themes of Pseudomonas aeruginosa, Colistin and Acinetobacter.
He most often published in these fields:
- Microbiology (50.56%)
- Antimicrobial susceptibility (20.00%)
- Antibiotic resistance (18.89%)
What were the highlights of his more recent work (between 2017-2021)?
- Microbiology (50.56%)
- Antimicrobial susceptibility (20.00%)
- Internal medicine (12.22%)
In recent papers he was focusing on the following fields of study:
Microbiology, Antimicrobial susceptibility, Internal medicine, Broth microdilution and Antimicrobial are his primary areas of study.
The Microbiology study combines topics in areas such as Staphylococcus pseudintermedius, Mycobacterium tuberculosis complex, Methicillin resistance, Agar and Klebsiella pneumoniae.
His study looks at the intersection of Mycobacterium tuberculosis complex and topics like Drug resistance with Antibiotic resistance.
His study in the fields of Retrospective cohort study under the domain of Internal medicine overlaps with other disciplines such as Safety studies.
His Antimicrobial research is multidisciplinary, relying on both Test, Dosing regimen, Pharmacokinetics, Susceptibility testing and Drug.
His studies deal with areas such as Pseudomonas aeruginosa and Acinetobacter as well as Agar plate.
Between 2017 and 2021, his most popular works were:
- MIC-based dose adjustment: facts and fables. (115 citations)
- Developmental roadmap for antimicrobial susceptibility testing systems (74 citations)
- Clinical bacteriology in low-resource settings: today's solutions (56 citations)
In his most recent research, the most cited papers focused on:
- Antibiotics
- Bacteria
- Internal medicine
His primary scientific interests are in Antimicrobial susceptibility, Microbiology, Antimicrobial, Internal medicine and Risk analysis.
His Antimicrobial susceptibility study is concerned with the larger field of Antibiotic resistance.
His Microbiology study typically links adjacent topics like Mycobacterium tuberculosis complex.
His Antimicrobial study combines topics from a wide range of disciplines, such as Pharmacokinetics, Therapeutic drug monitoring, Susceptibility testing and Intensive care medicine.
Gunnar Kahlmeter has researched Internal medicine in several fields, including Amphotericin B, Itraconazole, Posaconazole, Colistin and Polymyxin.
His Risk analysis study combines topics in areas such as Microbiological Techniques and Quality assurance.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
